Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance

SIMPLE SUMMARY: The use of targeted therapy has changed the clinical management of lung cancer patients, increasing both their life quality and expectancy. Conversely, the appearance of resistance occurs in almost all patients receiving this therapy. In this regard, new strategies combining differen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Mancini, Maicol, Thomas, Quentin-Dominique, Bourdel, Sylvia, Papon, Laura, Bousquet, Emilie, Jalta, Prisca, La Monica, Silvia, Travert, Camille, Alfieri, Roberta, Quantin, Xavier, Cañamero, Marta, Maraver, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307933/
https://ncbi.nlm.nih.gov/pubmed/34298655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados